Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erleada 60mg tablets
0803042V0BBAAAA
|
Erleada | Apalutamide | Malignant Disease and Immunosuppression | No data available |
|
Erlotinib 100mg tablets
0801050AEAAAAAA
|
Erlotinib | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Erlotinib 150mg tablets
0801050AEAAABAB
|
Erlotinib | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Erlotinib 25mg tablets
0801050AEAAACAC
|
Erlotinib | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Erwinase 10,000unit powder for solution for injection vials
0801050J0BBAAAA
|
Erwinase | Crisantaspase | Malignant Disease and Immunosuppression | No data available |
|
Estracyt 140mg capsules
0801010J0BBAAAA
|
Estracyt | Estramustine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Estramustine 140mg capsules
0801010J0AAAAAA
|
Estramustine phosphate | Estramustine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Ethyol 375mg powder for solution for infusion vials
0801000V0BBAAAA
|
Ethyol | Amifostine | Malignant Disease and Immunosuppression | No data available |
|
Ethyol 500mg powder for solution for infusion vials
0801000V0BBABAB
|
Ethyol | Amifostine | Malignant Disease and Immunosuppression | No data available |
|
Etopophos 100mg powder for solution for injection vials
0801040D0BDAAAG
|
Etopophos | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg capsules
0801040D0AAABAB
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg powder for solution for injection vials
0801040D0AAAGAG
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 100mg/5ml solution for infusion vials
0801040D0AAADAD
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 200mg/10ml solution for infusion vials
0801040D0AAAEAE
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 500mg/25ml solution for infusion vials
0801040D0AAAFAF
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Etoposide 50mg capsules
0801040D0AAAAAA
|
Etoposide | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 10mg tablets
0801050AXAAABAB
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 2.5mg tablets
0801050AXAAACAC
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 2mg dispersible tablets sugar free
0801050AXAAAGAG
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 3mg dispersible tablets sugar free
0801050AXAAAHAH
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 500microgram tablets
0801050AXAAAFAF
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 5mg dispersible tablets sugar free
0801050AXAAAIAI
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Evoltra 20mg/20ml concentrate for inf vials
0801030AABBAAAA
|
Evoltra | Clofarabine | Malignant Disease and Immunosuppression | No data available |
|
Extavia 300microgram inj vials
0802040M0BEAAAD
|
Extavia | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 100 tablets
0803020H0BCAAAC
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.